Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,115.00
+105.00 (2.62%)
At close: Jul 31, 2026
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 37.16 billion as of July 31, 2026. Its market cap has decreased by -43.09% in one year.
Market Cap
37.16B
Enterprise Value
16.05B
Revenue
78.58B
Ranking
n/a
PE Ratio
125.59
Stock Price
4,115.00
ChartMarket Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 37.16B, a decrease of -46.71%. That is a compound annual growth rate of -2.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 37.16B | -35.32% |
| Dec 30, 2025 | 57.46B | -6.51% |
| Dec 30, 2024 | 61.46B | -21.97% |
| Dec 28, 2023 | 78.77B | -19.25% |
| Dec 29, 2022 | 97.55B | -44.18% |
| Dec 30, 2021 | 174.75B | 62.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 227.37B |
| 3billion | 163.57B |
| GENINUS | 79.38B |
| Cytogen | 70.71B |
| Protia | 63.75B |
| GC Medical Science | 54.14B |
| Inventera | 54.12B |
| HLB Panagene | 46.98B |